Coagulation testing is one of the most ratio-sensitive draws in phlebotomy. The light blue sodium citrate tube is the only common collection tube where filling it incorrectly will guarantee a rejected specimen, and the lab will tell you about it. Get a CBC slightly underfilled? Usually fine. Underfill a citrate tube by 15 percent? The PT and aPTT come back falsely prolonged and the patient gets a phone call about a clotting workup they don't need. The whole game with coag draws is the ratio, the order, and the technique. Learn those three and you stop having tubes rejected.
Coagulation panels also drive serious clinical decisions. A patient on warfarin with an INR that's actually 2.4 but reads as 3.6 because of a short-fill might get their dose dropped, then bleed out a week later from a sub-therapeutic level. The lab can't fix what the phlebotomist did wrong at the chair. That's why this topic shows up so heavily on the NHA CPT and why every facility has strict citrate-tube protocols.
The Light Blue Tube: Sodium Citrate
The light blue top contains 3.2 percent sodium citrate as a liquid anticoagulant. Older tubes used 3.8 percent citrate. CLSI standardized 3.2 percent in the late 1990s because it produced more accurate PT and aPTT results across reagent systems. If a facility still has 3.8 percent tubes in stock, results from those tubes will not match results from 3.2 percent tubes for the same patient. Use what your lab supplies, check the label, and don't mix concentrations within a single draw.
Citrate works by binding free calcium ions in the blood. Calcium (Factor IV) is required at multiple steps in the coagulation cascade. Without free calcium, the cascade can't proceed, and the blood stays liquid in the tube. When the lab is ready to run the test, they add calcium back to the plasma in a controlled amount and time how long it takes to clot. That timed clot is the PT or aPTT result.
The critical detail: citrate is a reversible anticoagulant. EDTA chelates calcium so tightly that you can't recover it for testing. Citrate binds calcium loosely enough that the lab can overcome it with reagent calcium. That's the only reason coagulation testing works in a tube of anticoagulated blood. Use the wrong tube (lavender or green) and there's no way to test coag function.
The 9:1 Ratio Is Not Negotiable
The light blue tube is calibrated for a fill volume that produces a 9 parts blood to 1 part citrate ratio. The fill line is printed or etched on the tube, and most tube manufacturers also indicate it with a label arrow. Vacuum in the tube is set to pull exactly the right volume of blood when filled normally.
If the tube underfills, the ratio shifts. Less blood relative to the same volume of citrate means more citrate per milliliter of plasma. When the lab adds reagent calcium back to the plasma, more of that calcium gets bound up by the excess citrate before any coagulation can start. The clotting time gets falsely prolonged. A patient with a perfectly normal PT can read as 16 or 18 seconds when they should read 12.
If the tube overfills (rare with evacuated systems but possible with syringe transfers), there's too little citrate per milliliter of plasma. The cascade may partially activate in the tube before the test runs, or micro-clots may form. Results come back falsely shortened, masking a real coagulopathy. A patient with a true bleeding disorder might look normal.
Most labs reject light blue tubes that fall below approximately 90 percent of the fill line. Some are stricter at 95 percent. Check your facility policy. The visible vacuum-loss check matters too. If the tube was opened, dropped, or has a compromised stopper, it won't pull a full draw and will fail the fill check.
Tests Run on Citrated Blood
The coag panel isn't just PT and PTT. The light blue tube supports a wider menu than most students realize.
- PT (Prothrombin Time) measures the extrinsic and common pathways. It evaluates Factors I (fibrinogen), II (prothrombin), V, VII, and X. Used to monitor warfarin and screen for vitamin K deficiency or liver disease.
- aPTT (activated Partial Thromboplastin Time) measures the intrinsic and common pathways. It covers Factors I, II, V, VIII, IX, X, XI, and XII. Used to monitor unfractionated heparin and screen for hemophilia and lupus anticoagulant.
- INR (International Normalized Ratio) is a calculated value derived from the PT result and the reagent's ISI (International Sensitivity Index). Standardizes PT results across labs and reagent lots. Reported alongside PT.
- Fibrinogen (Factor I) quantitative testing. Low values point to consumption (DIC) or liver dysfunction.
- D-dimer measures fibrin degradation products. Elevated in DVT, PE, and DIC. Often the first test ordered to rule out clotting events.
- Individual factor assays (Factor VIII, IX, XI activity levels) for hemophilia workup.
- Lupus anticoagulant and antiphospholipid antibodies for thrombophilia evaluation.
All of these run on the same citrated plasma, which is why a single full light blue tube can support multiple add-on tests if collected properly.
INR and Why It Exists
The INR was created because PT results were impossible to compare across labs. Different reagent manufacturers use different thromboplastin sources (rabbit brain, recombinant human, bovine), and each has a different sensitivity to clotting factor levels. A patient with a PT of 18 seconds on one reagent might have a PT of 14 seconds for the same blood on another reagent. Useless for monitoring warfarin patients who move between providers.
The INR fixes this with a math correction. Each reagent lot ships with an ISI value that reflects how its sensitivity compares to a WHO reference thromboplastin. The lab calculates INR using the formula INR = (patient PT / mean normal PT) raised to the ISI power. The result: an INR of 2.5 means the same thing in any lab in the world.
Therapeutic ranges for warfarin patients are well established:
- 2.0 to 3.0 for atrial fibrillation, deep vein thrombosis (DVT), pulmonary embolism (PE), and most other indications.
- 2.5 to 3.5 for mechanical heart valves and recurrent thrombosis on standard-intensity warfarin.
- Below 2.0 means under-anticoagulated. Clot risk is elevated.
- Above 4.0 means over-anticoagulated. Bleeding risk is significant. Above 5.0 typically triggers a hold and possible vitamin K reversal.
Patients on warfarin get INR checks anywhere from every few days when starting, to every 4 weeks once stable. They become very familiar with the light blue tube. Treat them well at the chair and their veins will hold up over years of monthly draws.
Order of Draw: Citrate Comes Before EDTA
In the standard CLSI evacuated tube order, the light blue tube is second. Only blood cultures come before it. The reason is direct: EDTA contamination of citrated blood is the single worst pre-analytical error for coag testing.
EDTA is a powerful, irreversible calcium chelator. If even a few microliters of EDTA carry over from a lavender tube into a light blue tube via the needle, the citrate plus EDTA together strip out so much calcium that the lab cannot restore enough of it with reagent calcium. The PT and aPTT come back markedly prolonged. The patient looks like they have a clotting disorder when they don't.
The fix is structural. Draw the light blue early in the sequence so no other additive has touched the needle yet. Blood culture bottles first because they need a sterile draw, then light blue. After that, the order continues with red or SST, green heparin, lavender EDTA, and gray fluoride.
For syringe transfers, the rule flips. Light blue goes last because the dominant risk in syringe collection is underfilling the citrate tube as the syringe runs dry, not carryover. Different mechanism, different rule.
The Discard Tube Rule
This trips up new phlebotomists more than any other coag rule. When you collect a light blue citrate tube using a butterfly (winged infusion) set, the flexible tubing between the needle and the hub holds dead-air space. Around 0.5 mL depending on the set. That air goes into the first tube before blood does.
If the first tube is the light blue, the air displaces about 0.5 mL of the blood the tube was calibrated to draw. The tube finishes the fill cycle short. Ratio off. Specimen rejected. The fix is mechanical: draw a small discard tube first to clear the air, then draw the light blue.
The discard tube can be a plain red top or another empty light blue tube used as a discard only. It doesn't need to fill completely. Around 1 to 2 mL is enough to displace the air. Set it aside, then proceed with your light blue tube as the actual specimen.
Important caveats:
- Discard tube is required when using a butterfly with a coag tube, regardless of whether the coag tube is the only tube ordered.
- Discard is not required with a straight needle and tube holder. Straight-needle setups have no dead-air tubing.
- If the light blue is not the first tube on a multi-tube butterfly draw, no discard is needed. The first tube cleared the air for you.
Some facilities use a discard for every butterfly draw as a uniform policy. Others apply it strictly to coag-only or coag-first scenarios. Read your policy and follow it. The exam tests the coag-specific version of the rule.
Pre-Analytical Errors That Wreck Coag Results
Beyond fill volume and order of draw, several technique problems can ruin an otherwise correctly collected light blue tube.
Hemolysis. Hemolyzed plasma releases intracellular contents that interfere with the photo-optical clot detection most analyzers use. Some labs reject hemolyzed coag specimens outright. Avoid hemolysis by using a 21- or 22-gauge needle, not pulling too aggressively on a syringe, and not shaking the tube during inversion.
Clotted specimens. If the tube isn't inverted promptly after collection (3 to 4 gentle inversions), citrate doesn't mix evenly with the blood and small clots form. The lab tech checks for clots before running and rejects clotted samples. No clot detection assay can work on partially clotted blood.
Prolonged tourniquet time. A tourniquet on for more than 60 seconds causes hemoconcentration and tissue factor release at the puncture site, which can activate the clotting cascade. Release the tourniquet as soon as blood flow is established.
Drawing through an IV line. IV lines are commonly flushed with heparinized saline. Even after a flush, residual heparin can carry into the specimen and falsely prolong the aPTT. If you must draw from a line, discard at least 5 mL (or per facility policy) before collecting the coag specimen, and document that the draw was line-collected.
Wrong needle gauge. Needles smaller than 23 gauge cause shear stress on red cells and platelets, leading to hemolysis and platelet activation. Stick with 21 or 22 gauge for adult coag draws.
Storage and Stability
Most coag specimens are stable at room temperature for around 24 hours for PT and 4 hours for aPTT, though heparinized patients tighten that aPTT window further. Lab-specific protocols vary based on equipment and reagent. Ship promptly and don't leave tubes sitting on a counter overnight.
Refrigeration is generally not recommended for routine PT and aPTT because cold can activate Factor VII and Factor XI and shift results. Frozen plasma (after centrifugation and separation) is stable for weeks and is the standard for send-out coag testing.
Patients to Recognize
You'll draw certain populations regularly. Knowing why they're there helps you treat them well.
- Warfarin patients need INR every few days when starting therapy, then weekly to monthly once stable. They're often older, may have fragile veins, and want to be in and out fast.
- Heparin patients (usually inpatient) need aPTT every 6 hours during titration. They have IV access and you'll need to coordinate timing around the heparin drip rate, often drawing right before the next dose adjustment.
- Pre-surgical patients get a PT/INR and aPTT as part of pre-op clearance to identify undiagnosed coagulopathies before the OR. These are usually one-time draws with stable veins.
- DIC and trauma patients need rapid coag panels including fibrinogen and D-dimer. Often unstable, with poor venous access. STAT label and minimal handling.
- Hemophilia patients get factor assays. They know their veins better than you do. Listen.
Quick Scenarios
Scenario A: A nurse pages you to draw a CBC, a CMP, and a PT/INR on a 78-year-old in atrial fibrillation. You bring a butterfly set because his veins are thin. What's your tube order, and do you need a discard tube?
Order: light blue, gold SST, lavender. The light blue is the first tube on a butterfly draw, so yes, draw a small discard tube first (a plain red top is standard) to clear the dead-air space. Then proceed in CLSI order.
Scenario B: A patient on warfarin has an INR that comes back at 6.2 with no clinical bleeding. The provider asks if the result could be wrong. What pre-analytical errors should you check?
Underfilled citrate tube (most common cause of falsely high INR), specimen contamination with EDTA from order-of-draw error, draw from a heparinized IV line, or a delay in processing. Recollect with a verified-full light blue tube and a clean stick.
Scenario C: You collect a light blue tube from a butterfly draw without a discard tube. The tube reaches the fill line. Is it acceptable to send to the lab?
If the fill line is reached, the ratio is correct and the specimen is acceptable. The discard rule prevents underfilling, but if the tube fills despite skipping the discard (sometimes the air ends up trapped at the top without displacing enough blood to short-fill), the result is still valid. That said, always use the discard. Don't rely on luck.